Using FAC pretreatment followed by the Parkinson’s inducers, the α-synuclein levels were higher than the rotenone or 6-OHDA alone or dual treatments with FAC and rotenone or 6-OHDA (Figure 12A–C). Here, SNCA is linked to Parkinson disease.